Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 14, 2022 07:30 ET | Source: Spectral Medical Inc.

Spectral and Dialco Announce Dr. John Kellum to be Featured as Keynote Lecturer at the 40th Vicenza Course on AKI and CRRT 2022

TORONTO, June 14, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
June 13, 2022 07:30 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Adoption of SAMI Device by the Largest Inpatient Dialysis Provider in South Florida

TORONTO, June 13, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
May 16, 2022 07:30 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Appointment of Leading Industry Executive Sam Amory as Dialco President

TORONTO, May 16, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
May 13, 2022 07:30 ET | Source: Spectral Medical Inc.

Spectral Announces First Quarter Results and Provides Corporate Update

TORONTO, May 13, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
March 24, 2022 07:30 ET | Source: Spectral Medical Inc.

Spectral Announces Fourth Quarter and Fiscal 2021 Results and Corporate Update

TORONTO, March 24, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...
March 21, 2022 07:30 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Appointment of Blair McInnis as CFO

TORONTO, March 21, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...
March 16, 2022 08:00 ET | Source: Spectral Medical Inc.

Dialco Medical Announces Formation of Medical Advisory Board to Support the Continued Development of DIMI Device

TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its wholly owned subsidiary, Dialco Medical Inc. (“Dialco”), has...
March 04, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical CMO Dr. John Kellum to Present at the 27th International AKI & CRRT Conference on March 7-10, 2022

TORONTO, March 04, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...
February 11, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Reports Progress on Tigris Clinical Trial

Patient mortality data continues to exceed expectations Recent FDA approved SOFA amendment contributing to increased patient enrollment TORONTO, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Spectral Medical...
January 31, 2022 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces U.S. FDA Approval of DIMI Trial Protocol Amendment

TORONTO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its wholly-owned subsidiary, Dialco Medical Inc. (“Dialco”) has...